http://health.groups.yahoo.com/group/LymeInfo/message/433Association between multiple sclerosis and cystic structures in cerebrospinal fluid.
http://home.pon.net/caat/lyme/cyst_phase/MS_study.htm
LYME BORRELIOSIS AND MULTIPLE SCLEROSIS: ANY CONNECTION?
A SEROEPIDEMIC STUDY
http://www.aaem.pl/pdf/aaem0024.htm
Med Hypotheses. 2005;64(3):438-48.
Related Articles, Links
Chronic Lyme borreliosis at the root of multiple sclerosis--is a cure with antibiotics attainable?
Fritzsche M.
Clinic for Internal and Geographical Medicine, Soodstrasse 13, 8134 Adliswil, Switzerland. markus.fritzsche@gmx.ch
Apart from its devastating impact on individuals and their families, multiple sclerosis (MS) creates a huge economic burden for society by mainly afflicting young adults in their most productive years.
Although effective strategies for symptom management and disease modifying therapies have evolved, there exists no curative treatment yet.
Worldwide, MS prevalence parallels the distribution of the Lyme disease pathogen Borrelia (B.) burgdorferi, and in America and Europe, the birth excesses of those individuals who later in life develop MS exactly mirror the seasonal distributions of Borrelia transmitting Ixodes ticks.
In addition to known acute infections, no other disease exhibits equally marked epidemiological clusters by season and locality, nurturing the hope that prevention might ultimately be attainable.
As minocycline, tinidazole and hydroxychloroquine are reportedly capable of destroying both the spirochaetal and cystic L-form of B. burgdorferi found in MS brains, there emerges also new hope for those already afflicted.
The immunomodulating anti-inflammatory potential of minocycline and hydroxychloroquine may furthermore reduce the Jarisch Herxheimer reaction triggered by decaying Borrelia at treatment initiation. Even in those cases unrelated to B. burgdorferi, minocycline is known for its beneficial effect on several factors considered to be detrimental in MS.
Patients receiving a combination of these pharmaceuticals are thus expected to be cured or to have a longer period of remission compared to untreated controls. Although the goal of this rational, cost-effective and potentially curative treatment seems simple enough, the importance of a scientifically sound approach cannot be overemphasised.
A randomised, prospective, double blinded trial is necessary in patients from B. burgdorferi endemic areas with established MS and/or Borrelia L-forms in their cerebrospinal fluid, and to yield reasonable significance within due time, the groups must be large enough and preferably taken together in a multi-centre study.
PMID: 15617845 [PubMed - indexed for MEDLINE]
And on and on. Too many to list here. Many MS people have either gotten a LOT better or 'cured' after being treated for Lyme disease.
There are people who won't improve, of course. But my opinion is---- why not try a course (long) of antibiotics and see what happens.
Antibiotics are said to be 'dangerous' or 'destructive' if taken for a long time. That's a myth that has been passed around for a long time. Just ask any Lymie how long they've taken abx. 
And how much better they feel ------ IF they had Lyme disease.
"MDJ is so cool! I was able to work on all my problem areas separately but simultaneously. Eventually, with advice, support, direction and encouragement from a diverse bunch of genuine people, I began to heal and was able to put myself together as one unified whole. This site is one awesome tool!" (sharone)
